News
12-11-2009, 10:11 PM
Genomic Health, Inc. today announced results from a clinical survey evaluating the impact of the Oncotype DX® Recurrence Score® result on physicians' adjuvant treatment recommendations for patients with node-positive, hormone receptor-positive breast cancer.
More... (http://www.news-medical.net/news/20091212/Results-from-clinical-survey-of-Oncotype-DX-on-patients-with-node-positive-breast-cancer-announced.aspx)
More... (http://www.news-medical.net/news/20091212/Results-from-clinical-survey-of-Oncotype-DX-on-patients-with-node-positive-breast-cancer-announced.aspx)